NMRD Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 geg. 2024 @ 22:58):

Stats
Dzisiejszy wolumen	222 367
Średni wolumen	41 150.00
Kapitalizacja rynkowa	866 982
EPS	$-0.0700 ( 2024-02-23 )
Następna data zysków	( $-0.110 ) 2024-07-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0800
ATR14	$0.00400 (13.33%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-05	Ghadar-ghadr Arash	Buy	100 000	Common Stock
2022-01-05	Ghadar-ghadr Arash	Buy	0
2022-01-28	Natha Salim	Buy	8 000	Stock Option (right to buy)
2022-01-28	Moore Thomas Peter	Buy	8 000	Stock Option (right to buy)
2022-01-31	Mclarney Justin James	Buy	22 293	Common Stock

INSIDER POWER
100.00
Last 26 transactions
Buy: 137 623 617 \| Sell: 137 373 875

Nemaura Medical Inc Korelacja

10 Najbardziej pozytywne korelacje
BJDX	0.936
BXRX	0.923
ALVR	0.884
AGIL	0.879
MIST	0.87
CTSO	0.87
BNDX	0.869
ADN	0.864
NEO	0.853
EJH	0.848

10 Najbardziej negatywne korelacje
ARCE	-0.949
DSKE	-0.924
TIG	-0.898
XOMAP	-0.893
MRM	-0.892
IMRA	-0.883
NESR	-0.867
SGII	-0.866
NSTS	-0.849
ORTX	-0.847

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Nemaura Medical Inc Finanse

Annual	2023
Przychody:	$77 044.00
Zysk brutto:	$-1.48M (-1 916.30 %)
EPS:	$-1.010

FY	2023
Przychody:	$77 044.00
Zysk brutto:	$-1.48M (-1 916.30 %)
EPS:	$-1.010

FY	2022
Przychody:	$503 906
Zysk brutto:	$159 606 (31.67 %)
EPS:	$-0.590

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.280

Financial Reports:

No articles found.

Nemaura Medical Inc

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.